Print

Pro Top & Mediking Company Limited Announces The First And Revolutionary Collagen Matrix To Prevent Scar Formation For Glaucoma Filtration Microsurgery 
10/19/2005 5:12:28 PM

TAIPEI, Taiwan--(BUSINESS WIRE)--Dec. 14, 2004--Mediking Company today announces the successful development of OculusGen -- the scarring inhibitor for glaucoma filtration microsurgery & ophthalmic surgery. A biodegradable 3-dimensional porous collagen-glycosaminoglican scaffold, OculusGen is designed to prevent scar formation and to create a physiological aqua buffer environment for modulating the trabeculectomy and other ophthalmic surgery. Please visit www.OculusGen.com for more information.
//-->